Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Karyopharm Therapeutics (KPTI) Long-Term Debt Issuances (2024 - 2025)

Karyopharm Therapeutics' Long-Term Debt Issuances history spans 4 years, with the latest figure at $12.2 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances rose 114.71% year-over-year to $12.2 million; the TTM value through Dec 2025 reached -$71.0 million, up 14.71%, while the annual FY2025 figure was $12.2 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $12.2 million in Q4 2025 per KPTI's latest filing, up from -$83.3 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $12.2 million in Q4 2025 to a low of -$83.3 million in Q4 2024.